The National Medicines Agency (NMA) issued a statement clarifying the procedure for issuing the basic direct advance payments in response to recent inquiries. According to the agency, these payments are distributed in multiple stages. Notably, the NMA initiated the disbursement of these funds two months ahead of the originally scheduled timeline, commencing on August 17.
In the initial days of the payout period, significant funds were distributed, totaling nearly 74 million euros. These initial payments were directed to approximately 64,000 registered clients, and the agency confirmed that the process of issuing subsequent payments will continue according to the established schedule. The structure of the payments ensures that funds reach recipients progressively.
The rollout is designed to manage the financial flow while ensuring that eligible individuals receive their stipulated support. This staged approach allows the NMA to manage the logistics of paying out the substantial funds required for the advance payments across a large beneficiary base. The NMA emphasized that the payments are structured to support recipients through defined phases.
Stakeholders are advised to monitor official channels for updates regarding the next tranche of payments. The commitment remains to systematically pay out the necessary funds to all qualified parties, maintaining transparency throughout the distribution process.
Topics: #payments #advance #pay
